Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia

A Longitudinal Evaluation of Partial Lung Irradiation in Mice by Using a Dedicated Image-Guided Small Animal Irradiator

(2014) Patrick V. Granton et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Novel benzoxazines as inhibitors of angiogenesis

(2014) Sara Al-Rawi et al.   INVESTIGATIONAL NEW DRUGS

Signaling pathways in the development of infantile hemangioma

(2014) Yi Ji et al.   Journal of Hematology & Oncology

Endostar, a Modified Recombinant Human Endostatin, Suppresses Angiogenesis through Inhibition of Wnt/β-Catenin Signaling Pathway

(2014) Xiaoming Xu et al.   PLoS One

Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer

(2013) R. J. Kimple et al.   CANCER RESEARCH

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

(2013) Chuanliang Cui et al.   MOLECULAR THERAPY

Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma

(2013) Xuelin Zhang et al.   PATHOLOGY RESEARCH AND PRACTICE

Potential Reduction of Contralateral Second Breast-Cancer Risks by Prophylactic Mammary Irradiation: Validation in a Breast-Cancer-Prone Mouse Model

(2013) Igor Shuryak et al.   PLoS One

Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: Experimental and clinical evidence

(2013) Mao-Bin Meng et al.   RADIOTHERAPY AND ONCOLOGY

Assessing the Radiation Response of Lung Cancer with Different Gene Mutations Using Genetically Engineered Mice

(2013) Bradford A. Perez et al.   Frontiers in Oncology

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy

(2012) Weijing Sun   Journal of Hematology & Oncology

Can Determination of Circulating Endothelial Cells and Serum Caspase-Cleaved CK18 Predict for Response and Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Endostatin and Paclitaxel–Carboplatin Chemotherapy? A Retrospective Study

(2012) Tian-Qing Chu et al.   Journal of Thoracic Oncology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

(2011) Shom Goel et al.   PHYSIOLOGICAL REVIEWS

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

(2010) Y Loriot et al.   BRITISH JOURNAL OF CANCER

Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors

(2010) F. E. Escorcia et al.   CANCER RESEARCH

Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma

(2010) Inga Mandac et al.   Journal of Hematology & Oncology

Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells

(2010) Wei Zhuo et al.   JOURNAL OF PATHOLOGY

N-terminal modification increases the stability of the recombinant human endostatinin vitro

(2009) Li‑Ping Jiang et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Updates in Gastrointestinal Oncology – insights from the 2008 44th annual meeting of the American Society of Clinical Oncology

(2009) Milind Javle et al.   Journal of Hematology & Oncology

A New Target for Tumor Therapy

(2009) Rakesh K. Jain   NEW ENGLAND JOURNAL OF MEDICINE

Provascular strategy: Targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment

(2008) Pierre Sonveaux   RADIOTHERAPY AND ONCOLOGY